MEDIPOSTCO.,LTD.
Develops cord blood stem cell therapies for osteoarthritis & infant lung disease, plus banking.
078160 | KO
Overview
Corporate Details
- ISIN(s):
- KR7078160009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 대왕판교로 644번길21 -, 성남시
- Website:
- https://en.medi-post.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
MEDIPOST CO., LTD. is a global biotechnology company specializing in the development and commercialization of umbilical cord blood-derived stem cell therapeutics. The company focuses on regenerative medicine to address unmet medical needs. Its commercialized portfolio includes first-generation products such as CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. Alongside its therapeutic endeavors, MEDIPOST operates a significant private cord blood banking division for the collection and storage of stem cells. The company's research and development pipeline includes next-generation injectable and intravenous treatments for conditions like osteoarthritis (SMUP-IA-01) and diabetic nephropathy (SMUP-IV-01).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-03 00:00 | Pre-Annual General Meeting Information 주주명부폐쇄기간또는기준일설정               | Korean | 4.4 KB | ||
| 2025-09-01 00:00 | Report Publication Announcement 기업설명회(IR)개최               | Korean | 7.4 KB | ||
| 2025-08-18 00:00 | Report Publication Announcement 기업설명회(IR)개최               | Korean | 7.5 KB | ||
| 2025-08-14 00:00 | Interim Report 반기보고서 (2025.06) | Korean | 1.7 MB | ||
| 2025-07-10 00:00 | Report Publication Announcement 기업설명회(IR)개최               | Korean | 7.5 KB | ||
| 2025-06-09 00:00 | Report Publication Announcement 기업설명회(IR)개최               | Korean | 7.3 KB | ||
| 2025-05-15 00:00 | Quarterly Report 분기보고서 (2025.03) | Korean | 1.9 MB | ||
| 2025-03-28 00:00 | Board/Management Information 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | Korean | 9.9 KB | ||
| 2025-03-28 00:00 | Share Issue/Capital Change 주식매수선택권부여에관한신고 | Korean | 14.6 KB | ||
| 2025-03-28 00:00 | Post-Annual General Meeting Information 정기주주총회결과               | Korean | 36.3 KB | ||
| 2025-03-20 00:00 | Audit Report / Information 감사보고서제출               | Korean | 25.1 KB | ||
| 2025-03-20 00:00 | Annual / Quarterly Financial Statement 사업보고서 (2024.12) | Korean | 735.7 KB | ||
| 2025-03-17 00:00 | Report Publication Announcement 기업설명회(IR)개최               | Korean | 6.9 KB | ||
| 2025-03-13 00:00 | Pre-Annual General Meeting Information 주주총회소집공고 | Korean | 1.4 MB | ||
| 2025-03-13 00:00 | Proxy Solicitation & Information Statement 의결권대리행사권유참고서류 | Korean | 1.4 MB | 
Automate Your Workflow. Get a real-time feed of all MEDIPOSTCO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MEDIPOSTCO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MEDIPOSTCO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
 
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                    